FDA Warns Korean Device Facility for CGMP, MDR Violations
The Food and Drug Administration warned Korean device manufacturer Mi Gwang Contact Lens Co. that its premarket approval applications and federal contracts may be refused for violations of current good manufacturing practice (CGMP) requirements. The warning letter also detailed violations…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
of the Medical Device Reporting regulation. FDA told the company to respond to the allegations with corrective actions within 15 days of receipt of the Nov. 13 letter.